Drugs / sacubitril/valsartan
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07572032 Comparator | May 2026 → May 2028 expected | cardiac valvular defect, coronary artery disorder, heart failure | Kyungsub Song | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sacubitril/valsartan | “In the delayed-initiation arm, sacubitril/valsartan is withheld for 6 months after the corrective procedure; valsartan is used for blood pressure control and background heart...” NCT07572032 ↗ |
| Action | Inhibit | “ARNI (angiotensin receptor-neprilysin inhibitor)” NCT07572032 ↗ |